Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366726 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
A Phase 1 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT04366726 is a Phase 1 study that has completed, run by Radius Health. The registered enrollment target is 22 participants.
The verdict
NCT04366726, a Phase 1 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This was an open-label, single-center study to evaluate the usability of abaloparatide-sMTS by participants with low BMD.
Interventions
- COMBINATION_PRODUCT abaloparatide-sMTS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2019-05-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04366726
The ClinicalTrials.gov registry entry for NCT04366726 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radius Health, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which abaloparatide-sMTS is the first listed.
NCT04366726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04366726 about?
NCT04366726 is a clinical study titled "Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)". This was an open-label, single-center study to evaluate the usability of abaloparatide-sMTS by participants with low BMD.
What is the current status of trial NCT04366726?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2019-04-09. Estimated completion is 2019-05-14.
What interventions are being tested in trial NCT04366726?
The interventions under investigation include: abaloparatide-sMTS (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04366726?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.